WNC vs MCTA
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
WNC · Wabash National$10.91 ▼ 1.80%
MCTA · Charming Medical$29.36 ▲ 0.00%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- WNC +42.5%
- MCTA +6.7%
Head to head
| Metric | WNC | MCTA |
|---|---|---|
| Price | $10.91 | $29.36 |
| Change today | ▼ 1.80% | ▲ 0.00% |
| Market cap | $444.46M | $445.55M |
| Return, 3 months | -12.9% | 0.0% |
| Return, year to date | +29.2% | 0.0% |
| Return, 1 year | +44.4% | +32.8% |
| P/E (TTM) | – | – |
| P/B | 1.6 | 86.1 |
| P/E percentile vs own 5y | 22nd | 6th |
| Dividend yield | 2.20% | – |
| Revenue growth (YoY, latest qtr) | +24.8% | -22.7% |
| Net profit growth (YoY) | -150.8% | -101.9% |
| Gross margin | 0.9% | 62.6% |
| Operating margin | -10.1% | 2.7% |
| Net margin | -9.1% | -0.5% |
| Return on equity | -40.2% | -0.9% |
| Analyst target vs. price | +65.0% | – |
| Analyst buy share | 100% | – |
| RSI (14) | 33 | 78 |
| 30-day volatility | 62.2% | 0.0% |
| Max drawdown, 1 year | -43.8% | -25.6% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- MCTA is the largest of the group by market value.
- WNC has returned the most over the past year.
- WNC is growing revenue fastest.
- MCTA keeps the most profit per dollar of sales.
- MCTA has been the calmest stock over the last 30 days.